跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LEVOFLOXACIN-HAMELN SOLUTION FOR INFUSION 5MG/ML - HSA Drug Approval Details
Approvals
/
HSA
/
LEVOFLOXACIN-HAMELN SOLUTION FOR INFUSION 5MG/ML
Approved
THERAPEUTIC
LEVOFLOXACIN-HAMELN SOLUTION FOR INFUSION 5MG/ML
Siegfried Hameln GmbH
🇸🇬 Health Sciences Authority
Approval Date
Oct 8, 2019
Approval ID
b3690376c8342753
Company
Siegfried Hameln GmbH
Type
Therapeutic
Approval Details
Approval Id
b3690376c8342753
Drug Name
LEVOFLOXACIN-HAMELN SOLUTION FOR INFUSION 5MG/ML
Product Name
LEVOFLOXACIN-HAMELN SOLUTION FOR INFUSION 5MG/ML
Approval Number
SIN15827P
Approval Date
2019-10-08
Registrant
ZYFAS PHARMA PTE LTD
Licence Holder
ZYFAS PHARMA PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INFUSION, SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
J01MA12
Atc Item Name
levofloxacin
Pharma Manufacturer Name
ZYFAS PHARMA PTE. LTD.
Company Detail Path
/organization/zyfas-pharma-pte-ltd
Active Ingredients
Levofloxacin hemihydrate 5.13 mg eqv to Levofloxacin
5 mg/ml
Levofloxacin hemihydrate 5.13 mg eqv to Levofloxacin
5 mg/ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Oct 8, 2019
Approval ID
b3690376c8342753
Type
Therapeutic
Back to HSA Approvals
